Literature DB >> 29421950

Current and future challenges in pediatric severe asthma.

Amelia Licari1, Gian Luigi Marseglia1.   

Abstract

Entities:  

Year:  2018        PMID： 29421950     DOI： 10.1080/03007995.2018.1439463

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  6 in total

Review 1.  Biologics to Treat Severe Asthma in Children and Adolescents: A Practical Update.

Authors:  Gian Luigi Marseglia; Amelia Licari; Maria Angela Tosca; Giorgio Ciprandi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-11-13       Impact factor: 0.885

2.  Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives.

Authors:  Amelia Licari; Sara Manti; Riccardo Castagnoli; Giuseppe Fabio Parisi; Carmelo Salpietro; Salvatore Leonardi; Gian Luigi Marseglia
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.930

Review 3.  Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.

Authors:  Amelia Licari; Ilaria Brambilla; Alessia Marseglia; Maria De Filippo; Valeria Paganelli; Gian L Marseglia
Journal:  Front Pediatr       Date:  2018-06-19       Impact factor: 3.418

Review 4.  Novel therapeutic targets for allergic airway disease in children.

Authors:  Alessandro Giallongo; Giuseppe Fabio Parisi; Amelia Licari; Giulio Pulvirenti; Caterina Cuppari; Carmelo Salpietro; Gian Luigi Marseglia; Salvatore Leonardi
Journal:  Drugs Context       Date:  2019-07-09

Review 5.  Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?

Authors:  Mattia Giovannini; Francesca Mori; Simona Barni; Maurizio de Martino; Elio Novembre
Journal:  Ital J Pediatr       Date:  2019-11-28       Impact factor: 2.638

Review 6.  Immunotherapy and Asthma in Children.

Authors:  Maria A Tosca; Amelia Licari; Roberta Olcese; Gianluigi Marseglia; Oliviero Sacco; Giorgio Ciprandi
Journal:  Front Pediatr       Date:  2018-08-21       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.